推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 新產(chǎn)品放量銷售，業(yè)績(jī)重回高增長(zhǎng)。
公司發(fā)布中報(bào)，2015H實(shí)現(xiàn)營(yíng)業(yè)收入2.42億元，同比增長(zhǎng)63.6%；歸屬母公司凈利潤(rùn)3986萬(wàn)元，同比增長(zhǎng)50.7%；EPS0.16元，業(yè)績(jī)?cè)鲩L(zhǎng)符合預(yù)期。其中，Q2實(shí)現(xiàn)營(yíng)收1.57億元，同比增長(zhǎng)55.5%，環(huán)比增長(zhǎng)83%；歸屬母公司凈利潤(rùn)3093萬(wàn)元，同比增長(zhǎng)85.7%，環(huán)比增長(zhǎng)246%。納米氧化鋯、陶瓷墨水等新產(chǎn)品放量銷售，帶動(dòng)公司同比、環(huán)比業(yè)績(jī)大幅增長(zhǎng)。
公司顯著受益陶瓷墨水國(guó)產(chǎn)化進(jìn)程提速。
上半年建筑陶瓷系列(主要為陶瓷墨水、陶瓷色料、陶瓷釉料等)產(chǎn)品實(shí)現(xiàn)收入1.08億元，同比增長(zhǎng)198%；受益規(guī)模化及生產(chǎn)工藝優(yōu)化，產(chǎn)品毛利率41%，同比提高8個(gè)百分點(diǎn)。公司憑借“技術(shù)優(yōu)勢(shì)+渠道優(yōu)勢(shì)”將充納米復(fù)合氧化鋯下游開(kāi)拓順利，將成為公司重要利潤(rùn)增長(zhǎng)點(diǎn)。納米復(fù)合氧化鋯因其優(yōu)越的產(chǎn)品性能，廣泛應(yīng)用于特種結(jié)構(gòu)器件、光正式打破歐美國(guó)際壟斷。上半年納米氧化鋯實(shí)現(xiàn)銷售收入2049萬(wàn)元，同比增長(zhǎng)326%；隨著納米氧化鋯陸續(xù)投產(chǎn)以及擬增發(fā)方案中的3500噸產(chǎn)能擴(kuò)產(chǎn)，納米復(fù)合氧化鋯將成為公司重要的利潤(rùn)增長(zhǎng)點(diǎn)。
超細(xì)納米氧化鋁：性能優(yōu)越，市場(chǎng)空間巨大。
納米氧化鋁性能優(yōu)越，未來(lái)將受益于LED照明、高端手機(jī)防護(hù)屏、鋰電池薄膜等應(yīng)用領(lǐng)域的高速發(fā)展。憑借過(guò)硬的產(chǎn)品品質(zhì)、貼近服務(wù)等優(yōu)勢(shì)，鑫美宇將有機(jī)會(huì)成為國(guó)內(nèi)市場(chǎng)的主要供應(yīng)商，實(shí)現(xiàn)納米氧化鋁的進(jìn)口替代。(部分節(jié)選)
